Published in Neurology on May 01, 1995
Dementia incidence continues to increase with age in the oldest old: the 90+ study. Ann Neurol (2010) 2.09
Alzheimer's and dementia in the oldest-old: a century of challenges. Curr Alzheimer Res (2006) 1.20
Epidemiology of the dementias: recent developments and new approaches. J Neurol Neurosurg Psychiatry (1996) 1.12
Electromagnetic fields, oxidative stress, and neurodegeneration. Int J Cell Biol (2012) 1.10
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry (1998) 1.02
Deaths attributable to Alzheimer's disease in the United States. Am J Public Health (1999) 1.00
Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study. Alzheimers Dement (2012) 0.97
Identifying families with likely genetic protective factors against Alzheimer disease. Am J Hum Genet (1999) 0.95
Apolipoprotein E and familial longevity. Neurobiol Aging (2012) 0.93
A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet (1997) 0.93
Exceptional brain aging in a rural population-based cohort. J Rural Health (2009) 0.89
Dementia in the oldest old. Nat Rev Neurol (2013) 0.86
Reduced prevalence of cognitive impairment in families with exceptional longevity. JAMA Neurol (2013) 0.81
Memory activation in healthy nonagenarians. Neurobiol Aging (2009) 0.81
Aging is a weak but relentless determinant of dementia severity. Oncotarget (2016) 0.80
Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease. Virchows Arch (2015) 0.78
The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. PLoS One (2016) 0.77
Neuropathology of supercentenarians - four autopsy case studies. Acta Neuropathol Commun (2016) 0.75
Effects of the APOE ε4 allele and education on cognitive function in Japanese centenarians. Age (Dordr) (2016) 0.75
Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J (1991) 6.35
Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol (1993) 4.16
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med (1995) 3.54
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation (2001) 3.34
Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci U S A (1999) 3.07
A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E. Genomics (1990) 2.95
The homeostasis model in the San Antonio Heart Study. Diabetes Care (1997) 2.92
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care (1996) 2.35
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation : a prospective cohort study in men in eastern Finland. Circulation (1999) 2.29
Effects of supporting community-living demented patients and their caregivers: a randomized trial. J Am Geriatr Soc (2001) 2.28
Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study. J Intern Med (1997) 2.20
Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes (1995) 2.09
White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke (1995) 2.01
Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study. Neurology (2001) 1.98
Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation (1998) 1.98
Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry (2003) 1.90
Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology (2010) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut (2003) 1.87
White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol (1993) 1.86
Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study. Circulation (2000) 1.79
Short Portable Mental Status Questionnaire as a screening test for dementia and delirium among the elderly. J Am Geriatr Soc (1987) 1.76
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol (1999) 1.68
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Prevalence of severe dementia in Finland. Neurology (1985) 1.62
Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol (2000) 1.62
Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol (1999) 1.59
Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings. J Neurol Neurosurg Psychiatry (1983) 1.59
Relation of socioeconomic position to the case fatality, prognosis and treatment of myocardial infarction events; the FINMONICA MI Register Study. J Epidemiol Community Health (2001) 1.57
Telomere length and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hum Hypertens (2011) 1.56
Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med (1997) 1.55
Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci (2001) 1.52
APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology (2000) 1.51
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. J Clin Endocrinol Metab (1996) 1.49
Diagnostic features of acute myocardial infarction--changes over time from 1983 to 1990: results from the FINMONICA AMI Register Study. J Intern Med (1995) 1.49
Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab (1997) 1.49
Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J (1994) 1.48
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients. J Hum Hypertens (2001) 1.46
Neonatal diagnosis of familial hypercholesterolemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol (1997) 1.45
Differentiation of kidney mesenchyme in an experimental model system. Adv Morphog (1968) 1.44
Outcome of aged patients in Finnish supervised home care. Scand J Soc Med (1997) 1.43
You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation. Eur J Clin Invest (2003) 1.41
Calcific degeneration of the aortic valve in old age: is the development of flow obstruction predictable? J Intern Med (1996) 1.41
Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41
Gender differences in recurrent coronary events; the FINMONICA MI register. Eur Heart J (2001) 1.41
Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis (2001) 1.41
A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol (2001) 1.39
Coronary heart disease case fatality in four countries. A community study. The Acute Myocardial Infarction Register Teams of Auckland, Augsburg, Bremen, FINMONICA, Newcastle, and Perth. Circulation (1993) 1.37
Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med (1996) 1.36
The validity of hospital discharge register data on coronary heart disease in Finland. Eur J Epidemiol (1997) 1.36
A novel mutation of the fibrillin gene causing ectopia lentis. Genomics (1994) 1.36
Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol (1983) 1.36
Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry (1987) 1.36
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
Incidence of second hip fractures. A population-based study. Osteoporos Int (2007) 1.35
Creutzfeldt-Jakob disease: possible medical risk factors. Neurology (1985) 1.30
Primary structure of human insulin-like growth factor-binding protein/placental protein 12 and tissue-specific expression of its mRNA. FEBS Lett (1988) 1.29
Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol (1996) 1.29
Classic amyotrophic lateral sclerosis with dementia. Arch Neurol (1982) 1.26
Decline of coronary heart disease mortality in Finland during 1983 to 1992: roles of incidence, recurrence, and case-fatality. The FINMONICA MI Register Study. Circulation (1996) 1.24
Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology (1997) 1.23
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985. Eur Heart J (1992) 1.20
Associations between atrial natriuretic peptides, echocardiographic findings and mortality in an elderly population sample. J Intern Med (1997) 1.20
A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci U S A (1994) 1.20
Risk of harboring an unruptured intracranial aneurysm. Stroke (1998) 1.19
Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry (1988) 1.19
Bone density at the proximal femur after total hip arthroplasty. Clin Orthop Relat Res (1998) 1.19
Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings. J Hypertens (2000) 1.19
Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology (1996) 1.19
Self-reported and performance-based functional status and associated factors among elderly men: the Finnish cohorts of the Seven Countries Study. J Clin Epidemiol (1998) 1.17
Evaluation of periprosthetic bone using dual-energy x-ray absorptiometry: precision of the method and effect of operation on bone mineral density. J Bone Miner Res (1996) 1.17
Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia (1996) 1.15
Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome. J Biol Chem (1990) 1.15
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology (2002) 1.14
An extra cysteine in one of the non-calcium-binding epidermal growth factor-like motifs of the FBN1 polypeptide is connected to a novel variant of Marfan syndrome. J Clin Invest (1994) 1.13
Alzheimer's disease and senile dementia of Alzheimer type. A comparative study. Acta Neurol Scand (1982) 1.13
The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand (2003) 1.13
Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. J Clin Endocrinol Metab (2000) 1.11
Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb (1994) 1.11
Elevated risk of Alzheimer's disease among workers with likely electromagnetic field exposure. Neurology (1996) 1.11